TCL Archive Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’ August 9, 1991
TCL Archive “Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged” January 23, 1976
TCL Archive NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction April 28, 2006
TCL Archive ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research February 23, 1979
